Compare CVLT & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVLT | LNTH |
|---|---|---|
| Founded | 1996 | 1956 |
| Country | United States | United States |
| Employees | 3300 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 6.5B |
| IPO Year | 2006 | 2014 |
| Metric | CVLT | LNTH |
|---|---|---|
| Price | $168.49 | $100.11 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 10 |
| Target Price | ★ $163.49 | $106.99 |
| AVG Volume (30 Days) | 497.2K | ★ 984.6K |
| Earning Date | 10-27-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.50 | ★ 2.91 |
| Revenue | ★ $1,183,690,000.00 | $343,374,000.00 |
| Revenue This Year | $10.32 | N/A |
| Revenue Next Year | $11.31 | $12.19 |
| P/E Ratio | $328.55 | ★ $34.50 |
| Revenue Growth | ★ 18.89 | 3.62 |
| 52 Week Low | $71.75 | $50.16 |
| 52 Week High | $175.03 | $111.86 |
| Indicator | CVLT | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 65.79 | 49.06 |
| Support Level | $127.70 | $99.92 |
| Resistance Level | N/A | $100.40 |
| Average True Range (ATR) | 6.26 | 0.37 |
| MACD | 0.73 | 0.07 |
| Stochastic Oscillator | 93.60 | 55.92 |
CommVault Systems Inc provides cyber resiliency solutions designed to help the enterprise protect, secure, and recover its data, applications, and identity systems in a world of increasing cyber threats and attacks. Its offerings provide cyber resilience, including data protection, cyber recovery, data security, and governance, aiming to enable customers to continue business. The company delivers its solutions through Commvault Cloud, a cloud native platform that unifies data security, cyber recovery and identity resilience across on-premises, hybrid, multi-cloud, and software-as-a-service environments. It sells its offerings through subscription-based arrangements, including SaaS and term-based subscriptions, and also offers perpetual licenses, customer support, and professional services.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.